Alzheimer's Disease

A long-term study spanning 35 years has revealed men who participated in amateur boxing in their youth are almost three times more likely to suffer from Alzheimer’s-like cognitive impairment in their senior years compared to those who did not box.

A new study is reporting more than one in three patients trialing the recently approved Alzheimer’s drug aducanumab experienced brain swelling side effects. The data is the first from the drug’s Phase 3 trials to be peer-reviewed and published.

A University of Sussex study has demonstrated how a new type of quantum sensor could help doctors catch neurodegenerative diseases like Alzheimer’s earlier. The scanners precisely detect tiny changes in magnetic fields produced by firing neurons.

A new study has uncovered a previously unknown hairpin-like structure in a protein linked to Alzheimer's that proved to be critical to an antibody response seen in mice, laying the groundwork for a vaccine against the disease in humans.

Building on a growing body of evidence linking viral infections with neurodegenerative disease, a study has shown how molecules on the surfaces of viruses can promote the aggregation of toxic proteins seen with diseases such as Alzheimer’s and Parkinson’s.

Two new studies are building on a hypothesis that multiple sclerosis (MS) can be triggered by viral infections in a person’s teenage years. The research raises concerns the current COVID-19 pandemic could lead to a surge in MS cases in the future.

The interplay between high blood pressure and brain health is one scientists continue to shed new light on, with a new study finding even those with readings at the higher end of the normal recommended range can be at risk of premature brain aging.

Researchers on the hunt for a pre-approved medicine that can be repurposed to treat Alzheimer’s disease have found exposure to a common diuretic drug could significantly reduce a person’s risk of developing the disease.

Earlier detection of dementia could open up far more effective ways to treat and manage the condition. A new study has pinpointed "harbinger" molecules that could predict onset two to five years in advance, and may provide new targets for therapies.

A new study led by scientists from University College London proposes a key gene variant, known to heighten one’s risk for Alzheimer’s, stimulates the body’s inflammatory responses and can lead to greater susceptibility to severe COVID-19.

A drug originally designed to treat Alzheimer’s has been found to reduce obesity and improve heart function in mice. The drug was previously found to be ineffective treating dementia, but it's suggested it could be useful in stimulating fat metabolism.

A new study has explored how the blood-brain barrier might be shored up through the use of an existing anti-cancer drug, with the authors demonstrating some promising results around reversing cognitive decline in mice.